Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples